Protein Sciences will pitch Flublok to Connecticut home healthcare association; New biotech formed to develop cancer vaccines;

> Protein Sciences is partnering with the Connecticut Association for Healthcare at Home, which will enable it to sell its Flublok vaccine to member home-health and hospice agencies. News

> The Fight Against Cancer Innovation Trust and its partners formed Turnstone Biologics, a new biotech to develop cancer vaccines. Release

> A study published in Pediatrics showed that effectiveness of the Tdap vaccine for pertussis "decreases substantially" in adolescents after two to four years. News

> Gavi will continue to provide financial support for vaccinations and immunization programs in India, but only until 2020. Story

And Finally... The Chittoor District Medical and Health Department in India is scheduled to launch a pentavalent vaccine Thursday, but misspelled it as "pentaviolent" in a press release. An official went on to explain that the vaccine works "violently" against diseases. While a senior official later admitted the mistake, some continue to call it "violent." Story

Suggested Articles

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.

Univercells's new CDMO, Exothera, is hoping to play a role in helping drugmakers scale up manufacturing for a possible COVID-19 vaccine.